ILMN
32
-3
DTE
50
3
XOM
47
5
URBN
38
-4
PX
75
5
JWN
40
-2
AMP
69
-3
WDC
41
-2
STI
47
-12
TGNA
53
2
LB
34
8
NI
75
2
ZTS
47
2
IFF
53
2
VRTX
46
2
RRC
63
3
LUV
39
-5
FOXA
55
9
TEL
60
2
CINF
47
2
ILMN
32
-3
DTE
50
3
XOM
47
5
URBN
38
-4
PX
75
5
JWN
40
-2
AMP
69
-3
WDC
41
-2
STI
47
-12
TGNA
53
2
LB
34
8
NI
75
2
ZTS
47
2
IFF
53
2
VRTX
46
2
RRC
63
3
LUV
39
-5
FOXA
55
9
TEL
60
2
CINF
47
2
Financhill
Back

AC Immune SA Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
58

ACIU
AC Immune SA

Last Price:
3.21
Seasonality Move:
-0.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

AC Immune SA Price Quote

$3.21
-0.03 (-0.93%)
(Updated: November 21, 2024 at 10:15 AM ET)

AC Immune SA Key Stats

Buy
58
AC Immune SA (ACIU) is a Buy
Day range:
$3.22 - $3.41
52-week range:
$2.25 - $5.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.07%
Volume:
58.6K
Avg. volume:
119K
1-year change:
1.57%
Market cap:
$320.6M
Revenue:
$16.5M
EPS:
$-0.46

How Much Does AC Immune SA Make?

Data Unavailable

Is AC Immune SA Growing As A Company?

Data Unavailable

AC Immune SA Stock Price Performance

  • Did AC Immune SA Stock Go Up Last Month?
    AC Immune SA share price went up by 3.51% last month
  • Did ACIU's Share Price Rise Over The Last Year?
    ACIU share price rose by 1.57% over the past 1 year

What Is AC Immune SA 52-Week High & Low?

AC Immune SA Price To Free Cash Flow

Is It Risky To Buy AC Immune SA?

  • How Much Debt Does AC Immune SA Have?
    Total long term debt quarterly is $0
  • How Much Cash Does AC Immune SA Have?
    Cash and short term investments quarterly total is $187.7M
  • What Is AC Immune SA’s Book Value Per Share?
    Book value per share is 1.56

Is AC Immune SA Cash Flow Positive?

  • What Is ACIU Cash Flow From Operations?
    Cash flow from operations (TTM) is $52.1M
  • What Is AC Immune SA’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $44.6M
  • What Is AC Immune SA’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$92.2M

AC Immune SA Return On Invested Capital

  • Is Management Doing A Good Job?
    ACIU return on invested capital is -28.55%
  • What Is AC Immune SA Return On Assets?
    ROA measures how assets are converting to revenues and is -20.02%
  • What Is ACIU Return On Equity?
    ROE is a measure of profitability and is -28.55%

AC Immune SA Earnings Date & Stock Price

  • What Is AC Immune SA's Stock Price Today?
    A single share of ACIU can be purchased today for 3.24
  • What Is AC Immune SA’s Stock Symbol?
    AC Immune SA trades on the nasdaq under the ticker symbol: ACIU
  • When Is AC Immune SA’s Next Earnings Date?
    The next quarterly earnings date for AC Immune SA is scheduled on February 6, 2025
  • When Is ACIU's next ex-dividend date?
    AC Immune SA's next ex-dividend date is November 21, 2024
  • How To Buy AC Immune SA Stock?
    You can buy AC Immune SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AC Immune SA Competitors

  • Who Are AC Immune SA's Competitors?
    Below is a list of companies who compete with AC Immune SA or are related in some way:
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

AC Immune SA Dividend Yield

AC Immune SA Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 125.81%
Revenue: 0% 250.11%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.15
Upside from Last Price: 213.31%

Major Shareholders

  • How many ACIU shares are owned by institutional investors?
    46.5M ACIU shares are owned by institutional investors
  • How many ACIU shares are owned by insiders?
    0 ACIU shares are owned by insiders